GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » Capital Expenditure

Jacobio Pharmaceuticals Group Co (HKSE:01167) Capital Expenditure : HK$-12.96 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Jacobio Pharmaceuticals Group Co's cash flow for capital expenditures for the six months ended in Dec. 2024 was HK$-7.1 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-12.96 Mil.

Jacobio Pharmaceuticals Group Co Capital Expenditure Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Capital Expenditure Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial -12.99 -13.63 -18.43 -42.29 -12.91

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.30 -37.92 -4.37 -5.90 -7.06

Jacobio Pharmaceuticals Group Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-12.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jacobio Pharmaceuticals Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » Capital Expenditure
Comparable Companies
HKSE:01873 HKSE:01541 HKSE:02179 HKSE:02480 HKSE:02487 HKSE:02509 HKSE:01521 HKSE:06660 HKSE:06996 HKSE:02616 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
77V:Germany
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Website
https://www.jacobiopharma.com
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
Executives
Yakovpharma Ltd 2501 Other
Blesspharma Ltd 2501 Other
Honourpharma Ltd 2501 Other
Gloryviewpharma Ltd 2501 Other
Hmed Ltd 2501 Other
Johwpharma Ltd 2501 Other
Risepharma Ltd 2101 Beneficial owner
Willgenpharma Ltd 2501 Other
Hu Yunyan 2501 Other
Wang Xiaojie 2307 Founder of a discretionary trust who can infl
Wang Yinxiang 2501 Other
Qiming Corporate Gp Vi, Ltd. 2201 Interest of corporation controlled by you
Qiming Gp Vi, L.p. 2201 Interest of corporation controlled by you
Qiming Venture Partners Vi, L.p. 2101 Beneficial owner
Hillhouse Investment Management, Ltd. 2102 Investment manager

Jacobio Pharmaceuticals Group Co Headlines

No Headlines